A pharmaceutical composition comprising in a vehicle suitable for enteral, parenteral, topical or ocular administration, at least one aromatic benzamido compound having the formula ##STR13## wherein R.sub.1 represents --COR.sub.5 wherein R.sub.5 represents --OR.sub.6 wherein R.sub.6 represents hydrogen, lower alkyl or mono- or polyhydroxyalkyl,
- R.sub.2 represents 1-adamantyl,
- R.sub.3 represents alkyl having 1-10 carbon atoms,
- R.sub.4 represents hydrogen, lower alkyl or hydroxy, and the pharmaceutically acceptable salts of said aromatic benzamido compound of formula I when R.sub.6 represents hydrogen.